Artwork

In conversation with... Shun Lu

Listen to The Lancet

232 subscribers

published

iconShare
 
Manage episode 514571045 series 2409126
Content provided by The Lancet. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being presented at ESMO 2025.

  continue reading

700 episodes